Wilson Bryan
Director, Office of Tissues and Advanced Therapies • FDA
Wilson Bryan is a neurologist who graduated from the University of Chicago Pritzker School of Medicine. He served on the neurology faculty of the University of Texas Southwestern Medical School for 13 years. He has been an investigator on clinical trials in cerebrovascular disease and neuromuscular disorders, particularly amyotrophic lateral sclerosis. Dr. Bryan joined the United States Food and Drug Administration (FDA) in 2000, and now serves as Director of the Office of Tissues and Advanced Therapies (OTAT) in the FDA’s Center for Biologics Evaluation and Research (CBER)
Also Speaking
Suyash Prasad
Chief Medical Officer and Head of Research & Development • Taysha Gene Therapies
11 November 2022
David Sourdive
Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis
27 October 2022
Fran Gullo
Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics
9 November 2022
Also Speaking
2025 Downloadable Agenda
Download the post-event report for Advanced Therapies Week 2024.
8 October 2024
